Effects of icodextrin on the peritoneal membrane

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1373-1375

  Krediet, Raymond T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; DIALYSIS FLUID; GLUCOSE DERIVATIVE; ICODEXTRIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID DERIVATIVE; PENTOSIDINE;

ANGIOGENESIS; CELL VIABILITY; DIALYSATE; DRUG CYTOTOXICITY; DRUG SAFETY; FIBROSIS; GLYCOSYLATION; HUMAN; MESOTHELIUM; NONHUMAN; NOTE; PERITONEAL DIALYSIS; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FIBROSIS; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; PERITONEAL DIALYSIS; PERITONEUM; RATS;

EID: 77951682939     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq086     Document Type: Note

References (30)

1. Mistry CD, Gokal R, Pears E, et al. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46: 496-503 (Pubitemid 24253059)
2. Finkelstein F, Healy H, Abu-Alfa A, et al. Superiority of icodextrin compared with 4. 25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16: 546-554 (Pubitemid 41725153)
3. Konings CJAM, Kooman JP, Schonk M, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63: 1556-1563
4. Davies SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338-2394 (Pubitemid 37052381)
5. Ho-dac-Pannekeet MM, Schouten N, Langedijk MJ, et al. Peritoneal transport characteristics with glucose polymer dialysate. Kidney Int 1996; 50: 979-986 (Pubitemid 26302688)
6. Posthuma N, ter Wee PM, Verbrugh HA, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 240 h dialysate clearance. Nephrol Dial Transplant 1997; 12: 550-553 (Pubitemid 27105633)
7. Plum J, Gentile S, Verger C, et al. Efficacy and safety of a 7. 5% ico-dextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39: 862-871 (Pubitemid 34263363)
8. Martis L, Patel M, Gientych J, et al. Aseptic peritonitis due to pepti-doglycan contamination of pharmacopoeia standard dialysis solution. Lancet 2005; 365: 588-594 (Pubitemid 40247915)
9. Betjes MGH, Sampimon DR, Lingsma HF, et al. Risk factors associated with increasing incidence of encapsulation peritoneal sclerosis in a controlled multicenter study. Am Soc Nephrol 2009; poster F-PO1506
10. Ueda Y, Miyata T, Goffin CE, et al. Effect of dwell time on icodextrin and amino acid PD fluids. Kidney Int 2000; 58: 2518-2524
11. Schalkwijk CG, ter Wee PM, Teerlink T. Reduced 1, 2-dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and fluids based on glucose polymers or amino acids. Per i t Dial Int 2000; 20: 796-798
12. Liberek T, Topley N, Mistry CD, et al. Cell function and viability in glucose polymer peritoneal dialysis fluids. Perit Dial Int 1993; 13: 104-111 (Pubitemid 23141702)
13. De Fijter CW, Verbrugh HA, Oe LP, et al. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21: 411-418 (Pubitemid 23132907)
14. Thomas A, Schenk U, Fisher FP, et al. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Am J Kidney Dis 1997; 29: 246-253 (Pubitemid 27130736)
15. Cooker LA, Choo CG, Luneburg P, et al. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro. Adv Perit Dial 1999; 15: 17-20
16. Plum J, Lordnejad MR, Grabensee B. Effect of alternative dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. Kidney Int 1998; 54: 224-235 (Pubitemid 28288039)
17. De Waart DR, Zweers MM, Struijk DG, Krediet RT. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int 2001; 21: 269-274
18. Garcia-Lopez E, Pawlaczyk K, Anderstum B, et al. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis. Perit Dial Int 2007; 27: 415-420 (Pubitemid 47202194)
19. Wang T, Heimburger O, Cheng H, Bergström J, Lindholm B. Peritoneal fluid and solute transport with different polyglucose formulations. Perit Dial Int 1998; 18: 193-203 (Pubitemid 28221303)
20. Gotloib L, Wajsbrat V, Shostak A. Mesothelial dysplastic changes and lipid peroxidation induced by 7. 5% icodextrin. Nephron 2002; 92: 142-155 (Pubitemid 34983888)
21. Krediet RT, Zweers MM, van Westrhenen R, Zegwaard A, Struijk DG. Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD? NDT Plus 2008; IV56-IV62
22. Lee JH, Peddy DK, Saran R, et al. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin. Perit Dial Int 2000; 20: S39-S47
23. Nakao A, Nakao K, Takatori Y, et al. Effects of icodextrin peritoneal dialysis solution on peritoneal membrane in STZ induced-diabetic rats model with partial nephrectomy. Nephrol Dial Transplant current issue
24. Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, et al. Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 1007; 51: 888-893
25. Parikova A, Zweers MM, Struijk DG, Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin and glucose based dialysis solutions. Adv Perit Dial 2003; 19: 186-190
26. Rozenberg R, Magen E, Weissgasten J, Korzets Z. Icodextrin-in-duced sterile peritonitis: the Israeli experience. Perit Dial Int 2006; 26: 402-409 (Pubitemid 44340010)
27. Posthuma N, Verbrugh HA, Donker AJM, et al. Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years. Perit Dial Int 2000; 20: 174-180
28. Posthuma N, ter Wee PM, Niessen H, et al. Amadori albumin and advanced glycation end-products formation in peritoneal dialysis using icodextrin. Perit Dial Int 2001; 2: 43-51 (Pubitemid 32331717)
29. Martikeinen TA, Teppo AM, Grönhagen-Riska C, Ekstrand AV. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005; 25: 453-460 (Pubitemid 41448400)
30. Brown CB, Luciano AA, Martin D, et al. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind randomized, controlled study. Fertil Steril 2007; 88: 1413-1426 (Pubitemid 350030072)